AR089136A1 - Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen - Google Patents

Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen

Info

Publication number
AR089136A1
AR089136A1 ARP120104631A ARP120104631A AR089136A1 AR 089136 A1 AR089136 A1 AR 089136A1 AR P120104631 A ARP120104631 A AR P120104631A AR P120104631 A ARP120104631 A AR P120104631A AR 089136 A1 AR089136 A1 AR 089136A1
Authority
AR
Argentina
Prior art keywords
suppression
prevention
compositions containing
tumor growth
osteopontin
Prior art date
Application number
ARP120104631A
Other languages
English (en)
Spanish (es)
Inventor
Serena Anja
R Ritting Susan
Langborg Wejse Peter
Original Assignee
Arla Foods Amba
Forsyth Dental In Ry For Children D B A The Forsyth Inst F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods Amba, Forsyth Dental In Ry For Children D B A The Forsyth Inst F filed Critical Arla Foods Amba
Publication of AR089136A1 publication Critical patent/AR089136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP120104631A 2011-12-07 2012-12-10 Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen AR089136A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161567899P 2011-12-07 2011-12-07
US201261673912P 2012-07-20 2012-07-20
EP12177329 2012-07-20

Publications (1)

Publication Number Publication Date
AR089136A1 true AR089136A1 (es) 2014-07-30

Family

ID=48574961

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104631A AR089136A1 (es) 2011-12-07 2012-12-10 Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen

Country Status (12)

Country Link
US (1) US20150344534A1 (enExample)
EP (1) EP2788015A1 (enExample)
JP (1) JP2015500836A (enExample)
KR (1) KR20140104474A (enExample)
CN (1) CN104080472A (enExample)
AR (1) AR089136A1 (enExample)
AU (1) AU2012347468A1 (enExample)
BR (1) BR112014013565A2 (enExample)
CA (1) CA2858379A1 (enExample)
EA (1) EA201491010A1 (enExample)
WO (1) WO2013086459A1 (enExample)
ZA (1) ZA201404920B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014286123B2 (en) * 2013-07-05 2019-02-28 Arla Foods Amba Mammalian milk osteopontin for enhancing immune responsiveness
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
IL106576A (en) * 1992-08-13 2000-08-13 Immunotec Res Corp Ltd Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
AU773350B2 (en) * 1999-04-15 2004-05-20 Children's Medical Center Corporation Methods and compositions for modulating an immune response
US7259243B2 (en) * 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
RU2379975C2 (ru) * 2003-09-18 2010-01-27 Арла Фудс Амба Добавка в состав для детского питания
SM200600031B (it) * 2006-10-06 2009-05-11 Gianluca Mech Integratore alimentare con attivatore proteico
ES2538362T3 (es) * 2007-10-16 2015-06-19 Ventana Medical Systems, Inc. Clasificación, estadificación y pronóstico del cáncer mediante el uso de osteopontina-C

Also Published As

Publication number Publication date
EP2788015A1 (en) 2014-10-15
US20150344534A1 (en) 2015-12-03
WO2013086459A1 (en) 2013-06-13
AU2012347468A1 (en) 2014-06-26
KR20140104474A (ko) 2014-08-28
ZA201404920B (en) 2015-12-23
CA2858379A1 (en) 2013-06-13
EA201491010A1 (ru) 2015-01-30
CN104080472A (zh) 2014-10-01
JP2015500836A (ja) 2015-01-08
BR112014013565A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2021006531A (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
SV2017005489A (es) Terapias de combinación para el tratamiento de cánceres
MX2016015434A (es) Combinaciones farmaceuticas para tratar cancer.
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
NI201400111A (es) Tratamiento del cáncer con inhibidores tor cinasa
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
AR079160A1 (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.
CO6741197A2 (es) Proteína de fusión robo1-fc para uso en el tratamiento del hepatocarcinoma
PH12020550462A1 (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same
CL2013003324A1 (es) Composicion que comprende quimioterapia con paclitaxel y carboplatino y un oligonucleotido anti-clusterina; uso de la composición para el tratamiento de un paciente humano que padece cancer de pulmón.
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
AR089136A1 (es) Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen
CL2011003248A1 (es) Composicion farmaceutica que comprende crf y un inhibidor de angiogenesis; util para la prevencion y el tratamiento del cancer.
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
DOP2014000221A (es) Métodos para tratar el cáncer usando inhibidor de pi3k e inhibidor de mek

Legal Events

Date Code Title Description
FB Suspension of granting procedure